Chest Meeting
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


COPYRIGHT © 2005 by the American College of Chest Physicians.
This Article
Right arrow Full Text (PDF)
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Antonangelo, L.
Right arrow Articles by Teixeira, L. R.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Antonangelo, L.
Right arrow Articles by Teixeira, L. R.

Pleural Disease


Wednesday, November 2, 2005

12:30 PM - 2:00 PM

DOES STORAGE TIME AND TEMPERATURE INTERFERE IN THE ADENOSINE DEAMINASE MEASUREMENT IN PLEURAL EFFUSIONS?

Leila Antonangelo, MD*, Francisco S. Vargas, MD, Luciana P. Almeida, PharmD, Milena M. Acencio, BS, Fabrício D. Gomes, BS, Roberta K. Sales, MD, Márcia Seiscento, MD and Lisete R. Teixeira, MD

Pulmonary Division, Heart Institute (InCor) and Department of Pathology of Univer, Sao Paulo, Brazil

PURPOSE: To evaluate the interference of pre-analytic factors as storage time and temperature in pleural fluid adenosine deaminase (ADA) measurement in pleural effusions.

METHODS: 27 pleural effusions obtained from patients with neoplasm (20) or tuberculosis (07) were analyzed. The pleural effusions were collected into tubes containing EDTA. The ADA determination was realized 1, 3, 7, 10 and 28 days after the toracocentesis and the samples were stored at 4°C (refrigerator) or -20°C (freezer). The ADA determined immediately after the pleural collection (T1) was used as gold standart to the comparison with the results obtained from the other times. The ADA activity was determined by the modified Giusti method. Statistical analysis: The Wilcoxon test was used to compare T1 with the resuts obtained at 1, 3, 7, 10 and 28 days, for both temperatures. We used the Pearson coefficient to evaluate the correlation between T1 and the other times evaluated.

RESULTS: Pleural ADA from T1 was 36.45 U/L (23.2 ± 55.1). We do not observe differences statistically significant between this measurement with those obtained from 1, 3, 7, 10 and 28 days, for both temperatures (4°C or -20°C). The correlations between T1 and the other times were superior to 0.90 until the tenth day for both temperatures, with a tendency of decreasing around the 28th for the temperature of 4°C (r= 0.86) or -20°C(r=0.83).

CONCLUSION: ADA levels are stable for at least 28 days in samples of pleural fluids if they were maintained refrigerated (4°C) or freezed (20°C).

CLINICAL IMPLICATIONS: Considering that samples of pleural effusion can be sended to ADA determination many hours after the toracocentesis or that frequently we have to confirm ADA results, we consider safe to quantify this enzyme until at least 28 days after the collection, if the samples were maintained at refrigerator or freezer.

DISCLOSURE: Leila Antonangelo, None.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by the American College of Chest Physicians.